main content start
Segluromet (ertugliflozin and metformin) is a type 2 diabetes oral medication in the SGLT-2 inhibitor class of drugs. It blocks glucose from being reabsorbed by the kidneys. Excess glucose is released in the urine. Some medications in the SGLT-2 inhibitor class may offer heart and kidney benefits for people with cardiovascular disease.
- Segluromet helps the kidneys to get rid of glucose in the bloodstream and the liver to release lower amounts of glucose into the bloodstream to improve blood glucose management in adults with type 2 diabetes.
- It is not for treating type 1 diabetes.
- Medications like Segluromet may offer heart and kidney benefits for people with cardiovascular disease.
- Segluromet is usually taken twice per day with meals at an individualized dose based on the patient's current medication regimen.
- Common side effects may include genital-urinary infection, stomach discomfort, nausea, vomiting, diarrhea, gas, headache, weakness, or urinating more than usual.
Segluromet Specs
Key specification
Generic Name
Ertugliflozin and Metformin
Drug Class
SGLT-2 inhibitors
General Information
Product Name
Segluromet
Product Type
Oral Medications
Brand
Merck
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
